GNAI2 and hepatocellular carcinoma: AAV-9-shGαi2: Chen et al. have identified Gαi2 (G protein subunit alpha i2) as a potential therapeutic target and diagnostic marker for HCC due to its overexpression in HCC tissues and cells, which is associated with a less favorable prognosis for patients.